REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its molecules alone or in establishing targeted collaborations with academic researchers, or also in partnerships with companies interested in developing its own therapeutic molecules.
Company Details
- Founded
- 2013
- Address
- 102 Avenue Gaston Roussel, Romainville,93230,france
- Phone
- 33660904124
- re****@****xis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- regulaxis.com
- Keywords
- Osteoarthritis, Cancer, Acromegaly.
- HQ
- Romainville
Regulaxis Sas Questions
Regulaxis Sas's helpline number is 33660904124
Regulaxis Sas's website is regulaxis.com
Regulaxis Sas's LinkedIn profile is https://fr.linkedin.com/company/regulaxis-sas
Regulaxis Sas's industry is
Biotechnology Research
Regulaxis Sas's top competitors are
Bepatient,
Biotypage,
Hempetik,
Redcat Biosciences,
Mitologics,
Bioguess,
Visiomed Ag,
Socosur Chem.,
Icanc,
Tox By Design.
Regulaxis Sas's support email address is regulaxis@regulaxis.com
Regulaxis Sas's categories are Biotechnology Research
Regulaxis Sas's founding year is 2013
